• Home

  • About Us

    • Executive Committee
    • NIH/NHLBI Project Officers
    • Steering Committee
    • PRC/DSMB
    • Clinical Coordinating Center
    • Network Staff
    • Clinical Endpoints Committee
    • Data Coordinating Center
  • About the Trial

  • For Professionals

    • Specific Aims
    • Protocol Synopsis
    • Literature
    • Ancillary Studies
  • For Investigators

  • Trial News

  • Find a Trial Site

  • Contact Us

  • More

    Use tab to navigate through the menu items.

    INfluenza Vaccine to Effectively Stop cardioThoracic Events and Decompensated heart failure Trial

    Literature

    Vardeny et al. 

    High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial

    ​

    Vardeny et al.

    Decreased Immune Responses to Influenza Vaccination in Patients With Heart Failure

     

    Udell et al.

    Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients - A Meta-analysis

     

    Vardeny et al.

    Influenza Vaccination in Patients With Chronic Heart Failure - The PARADIGM-HF Trial

    ​

    Ermen et al.

    Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study

    ​

    Wang et al.

    High-dose influenza vaccine in older adults

    ​

    Udell et al.

    Does influenza vaccination influence cardiovascular complications?

    ​

    ​

    Albrechet et al.

    Lack of Persistence of Influenza Vaccine Antibody Titers in Patients With Heart Failure

     

    ​

    INVESTED Trial

    Sponsored by:

    National Institutes of Health  ● National Heart, Lung, and Blood Institute

    investedtrial@partners.org

    clinicaltrials.gov listing

    857-307-0634

    • Facebook Social Icon
    • Twitter Social Icon